A year of rebuilding and renewed focus

Bioretec Finland

A recording of the webcast can be viewed at the same address later the same day.

During the event, Bioretec's CEO Sarah van Hellenberg Hubar-Fisher and CFO Tuukka Paavola will review the 2025 results and the main events of the review period. The event is held in English.

Tampere, 13 February 2026
Board of Directors
Bioretec Ltd.

For additional information:
Sarah van Hellenberg Hubar-Fisher, CEO
[phone]
[e-mail]

Tuukka Paavola, CFO
[phone]
[e-mail]

Certified Adviser
Nordic Certified Adviser AB, [phone]

Information about Bioretec

Bioretec is a globally operating Finnish medical device pioneer at the forefront of transforming orthopedic care with fully biodegradable implant technologies. The company has built unique competencies in the biological interface of active implants to enhance bone growth and accelerate fracture healing after orthopedic surgery. The products developed and manufactured by Bioretec are used worldwide in approximately 40 countries. 

The company's latest innovation, the RemeOs™ product line, is based on a high-performance magnesium alloy and hybrid composite, introducing a new generation of strong absorbable materials for enhanced surgical outcomes. The RemeOs implants are absorbed and replaced by bone, which eliminates the need for removal surgery while facilitating fracture healing. The first RemeOs product market authorization was received in the U.S. in March 2023, and in Europe, the CE mark approval was received in January 2025.

Bioretec's Activa product line features fully bioabsorbable orthopedic implants made from a proprietary, self-reinforced PLGA both CE marked and FDA cleared for a wide range of indications in adult and pediatric patients.

Bioretec is shaping the future of orthopedic treatment with a focus on healing through absorption, paving the way for more effective and patient-friendly solutions.

To learn more about Bioretec, visit www.bioretec.com

Appendix

Bioretec Ltd's financial statements bulletin January–December 2025 (pdf)

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/bioretec/r/a-year-of-rebuilding-and-renewed-focus,c4306941

The following files are available for download:

https://mb.cision.com/Public/20509/4306941/89a642aad9f79c7c.pdf

Bioretec ENG Financial statements bulletin 2025

 

View original content:https://www.prnewswire.co.uk/news-releases/a-year-of-rebuilding-and-renewed-focus-302687477.html